How much profit has Dimerix made this year?
Dimerix has made -13.25 M AUD this year.
Dimerix Net Income 2025
Dimerix Net Income
-13.25 M AUD
Ticker
DXB.AX
ISIN
AU000000DXB7
In 2025, Dimerix's profit amounted to -13.25 M AUD, a -22.39% increase from the -17.08 M AUD profit recorded in the previous year.
The Dimerix Net Income history
| YEAR | NET INCOME (k AUD) |
|---|---|
| 2025 | -13,251.7 |
| 2024 | -17,075.1 |
| 2023 | -13,802.8 |
| 2022 | -10,490.6 |
| 2021 | -6,371.7 |
| 2020 | -4,494.2 |
| 2019 | -2,886.2 |
| 2018 | -3,319.7 |
| 2017 | -1,758.5 |
| 2016 | -5,254.5 |
| 2015 | -679.5 |
| 2014 | -530 |
| 2013 | -520 |
| 2012 | -390 |
| 2011 | 10 |
| 2010 | -350 |
| 2009 | -4,130 |
| 2008 | -3,560 |
| 2007 | -2,420 |
| 2006 | -11,160 |
Dimerix Revenue, EBIT, Net Income
3 years
5 years
10 years
25 Years
Max
Loading chart...
Revenue
EBIT
Net Income
Details
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Dimerix, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Dimerix from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Dimerix’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Dimerix. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Dimerix’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Dimerix’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Dimerix’s growth potential.
Dimerix Revenue, EBIT and net profit per share
| Date | Dimerix Revenue | Dimerix EBIT | Dimerix Net Income |
|---|---|---|---|
| 2025 | 5.91 M undefined | -31.01 M undefined | -13.25 M undefined |
| 2024 | 583,500 undefined | -16.92 M undefined | -17.08 M undefined |
| 2023 | 36,800 undefined | -13.75 M undefined | -13.8 M undefined |
| 2022 | 2,400 undefined | -10.44 M undefined | -10.49 M undefined |
| 2021 | 1,500 undefined | -6.32 M undefined | -6.37 M undefined |
| 2020 | 2,700 undefined | -4.49 M undefined | -4.49 M undefined |
| 2019 | 18,100 undefined | -2.89 M undefined | -2.89 M undefined |
| 2018 | 20,200 undefined | -3.32 M undefined | -3.32 M undefined |
| 2017 | 18,300 undefined | -1.76 M undefined | -1.76 M undefined |
| 2016 | 45,300 undefined | -1.28 M undefined | -5.25 M undefined |
| 2015 | 31,400 undefined | -579,500 undefined | -679,500 undefined |
| 2014 | 40,000 undefined | -550,000 undefined | -530,000 undefined |
| 2013 | 130,000 undefined | -340,000 undefined | -520,000 undefined |
| 2012 | 160,000 undefined | -260,000 undefined | -390,000 undefined |
| 2011 | 480,000 undefined | 10,000 undefined | 10,000 undefined |
| 2010 | 60,000 undefined | -350,000 undefined | -350,000 undefined |
| 2009 | 30,000 undefined | -480,000 undefined | -4.13 M undefined |
| 2008 | 800,000 undefined | -2.7 M undefined | -3.56 M undefined |
| 2007 | 680,000 undefined | -2.47 M undefined | -2.42 M undefined |
| 2006 | 70,000 undefined | -3.02 M undefined | -11.16 M undefined |
Dimerix stock margins
The Dimerix margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Dimerix. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Dimerix.
3 years
5 years
10 years
25 Years
Max
Loading chart...
Gross margin
EBIT margin
Profit margin
Details
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Dimerix's sales revenue. A higher gross margin percentage indicates that the Dimerix retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Dimerix's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Dimerix's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Dimerix's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Dimerix. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Dimerix's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Dimerix Margin History
| Dimerix Gross margin | Dimerix Profit margin | Dimerix EBIT margin | Dimerix Profit margin |
|---|---|---|---|
| 2025 | 60 % | -524.31 % | -224.08 % |
| 2024 | 60 % | -2,900.17 % | -2,926.32 % |
| 2023 | 60 % | -37,352.17 % | -37,507.61 % |
| 2022 | 60 % | -435,162.5 % | -437,108.3 % |
| 2021 | 60 % | -421,466.65 % | -424,780 % |
| 2020 | 60 % | -166,451.86 % | -166,451.86 % |
| 2019 | 60 % | -15,945.86 % | -15,945.86 % |
| 2018 | 60 % | -16,434.16 % | -16,434.16 % |
| 2017 | 60 % | -9,609.29 % | -9,609.29 % |
| 2016 | 60 % | -2,824.72 % | -11,599.34 % |
| 2015 | 60 % | -1,845.54 % | -2,164.01 % |
| 2014 | 60 % | -1,375 % | -1,325 % |
| 2013 | 60 % | -261.54 % | -400 % |
| 2012 | 60 % | -162.5 % | -243.75 % |
| 2011 | 60 % | 2.08 % | 2.08 % |
| 2010 | 60 % | -583.33 % | -583.33 % |
| 2009 | 60 % | -1,600 % | -13,766.67 % |
| 2008 | 60 % | -337.5 % | -445 % |
| 2007 | 83.82 % | -363.24 % | -355.88 % |
| 2006 | 100 % | -4,314.29 % | -15,942.86 % |
Dimerix Aktienanalyse
What does Dimerix do?
Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Dimerix's Profit Margins
The profit margins of Dimerix represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Dimerix's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Dimerix's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Dimerix's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Dimerix’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Dimerix stock
How has the profit developed compared to last year?
The profit has increased by -22.39% compared to last year fallen
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Dimerix publish its earnings?
Dimerix publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Dimerix?
The profits of Dimerix are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Dimerix?
You can learn more about the earnings of Dimerix by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Dimerix pay?
Over the past 12 months, Dimerix paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Dimerix is expected to pay a dividend of 0 AUD.
What is the dividend yield of Dimerix?
The current dividend yield of Dimerix is .
When does Dimerix pay dividends?
Dimerix pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Dimerix?
Dimerix paid dividends every year for the past 0 years.
What is the dividend of Dimerix?
For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Dimerix located?
Dimerix is assigned to the 'Health' sector.
Wann musste ich die Aktien von Dimerix kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Dimerix from 10/29/1999 amounting to 0.008 AUD, you needed to have the stock in your portfolio before the ex-date on 9/24/1999.
When did Dimerix pay the last dividend?
The last dividend was paid out on 10/29/1999.
What was the dividend of Dimerix in the year 2024?
In the year 2024, Dimerix distributed 0 AUD as dividends.
In which currency does Dimerix pay out the dividend?
The dividends of Dimerix are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Dimerix
Our stock analysis for Dimerix Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dimerix Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
